Product Program year 2021 Source: CMS Open Payments

HeartMate 3 Left Ventricular Assist Device

Device Heart failure

PDI 00813024013297

Open in the dashboard

General payments

$1,041,380

9,092 payments

Research payments

$2,320,052

883 payments

Through program year 2021, $1,041,380 in general payments and $2,320,052 in research payments were reported against HeartMate 3 Left Ventricular Assist Device (Heart failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $1,041,380 9,092
2021 Research $2,320,052 883

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $1,041,380 9,092 payments
Top recipients General payments · program year 2021
  1. David Morales Thoracic Surgery (Cardiothoracic Vascular Surgery) · Cincinnati, OH $47,829 5% · 30 payments
  2. Angela Lorts Pediatric Cardiology · Cincinnati, OH $33,350 3% · 27 payments
  3. Jennifer Cowger Advanced Heart Failure and Transplant Cardiology · Detroit, MI $21,919 2% · 31 payments
  4. Brigham And Womens Hospital Teaching hospital · MA $21,000 2% · 12 payments
  5. Gregory Egnaczyk Advanced Heart Failure and Transplant Cardiology · Cincinnati, OH $19,575 2% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $283,911 28% · 351 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $262,961 26% · 345 practitioners
  3. Cardiovascular Disease Internal Medicine $148,560 15% · 746 practitioners
  4. Pediatric Cardiology Pediatrics $47,453 5% · 54 practitioners
  5. Interventional Cardiology Internal Medicine $29,496 3% · 294 practitioners

The top 5 of 93 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Ohio $157,940 15% · 142 recipients
  2. Texas $120,879 12% · 587 recipients
  3. New York $87,307 8% · 320 recipients
  4. Illinois $78,697 8% · 181 recipients
  5. California $66,922 6% · 185 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

9,092 general · 883 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record